Alembic Pharmaceuticals Limited informed that with effect from 1st January, 2024,due to internal change in reporting structures, Mr. Prerepa Sreenivasa Rao, Head Quality (Sterile) shall report to the Head Global Quality of the Company and hence ceases to be a Senior Management Personnel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990.2 INR | -0.73% | +5.53% | +30.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.40% | 2.33B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Alembic Pharmaceuticals Limited Cessation of Mr. Prerepa Sreenivasa Rao as Senior Management Personnel